ghk-cu hair growth clinical study humans GHK Peptide Trial (2016) — Research Summary ghk-cu hair growth clinical trial

10.1111/j.1526-4637.2012.01335.x 96 PeyravianN.SunE.DikiciE.DeoS.DaunertS.ToborekM

A special trampoline test can be done to see if the fibrocartilage disk is okay

The standard combination protocol uses BPC-157 at 0.25-0.5 mg daily alongside TB-500 at 2-5 mg weekly during a loading phase of 4 weeks, followed by TB-500 maintenance at 2-3 mg weekly while continuing daily BPC-157

Cochrane Database Syst Rev 2018

Injection-site reactions Community reports cluster around mild redness or itching at the subcutaneous injection site, typically lasting under 24 hours

Highlights The starting tirzepatide dosage for weight management is low (2.5 mg weekly) and is increased slowly (by 2.5 mg weekly after at least 4 weeks) because side effects are common but usually temporary and manageable